Research Project
Grant-in-Aid for Young Scientists (B)
Glioblastoma is the most common and most aggresive tumor in adults. One of the factors of treatment resistence is the existence of hypoxic regions located in the tumor. Cu-ATSM (Cu-diacetyl-bis(N4-methylthiosemicarbazone)) was developed as a hypoxic tracer in PET. Our previous reports revealed a relationship between Cu-ATSM uptake and hypoxic marker expression. If the treatment resistent factors are mainly existed in the hypoxic regions of glioblastoma, the safe treatment targeted the hypoxic regions such as stereotactic strategy becomes possible. In this study, we took the hypoxix tissue at the surgery, and performed immunopathological examinations and gene analysis. Moreover, we examined the target therapy for Cu-ATSM high uptake regions. Now we follow up the clinical course and examine the relationship of tissue status and clinical outcome.
All 2017 2016
All Journal Article (1 results) (of which Peer Reviewed: 1 results, Open Access: 1 results) Presentation (1 results)
Sci Rep.
Volume: 7 Issue: 1 Pages: 42783-42783
10.1038/srep42783